Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-14 3:32 pm Sale | 13G | VISTAGEN THERAPEUTICS INC VTGN | ACUTA CAPITAL PARTNERS LLC | 0 0.000% | -11,736,283 (Position Closed) | View |
2023-02-14 3:29 pm Sale | 13G | Jiya Acquisition Corp. JYAC | ACUTA CAPITAL PARTNERS LLC | 0 0.000% | -562,500 (Position Closed) | View |
2023-02-14 3:26 pm Sale | 13G | BCLS Acquisition Corp. BLSA | ACUTA CAPITAL PARTNERS LLC | 0 0.000% | -843,122 (Position Closed) | View |
2022-02-15 2:51 pm Sale | 13G | VISTAGEN THERAPEUTICS INC VTGN | ACUTA CAPITAL PARTNERS LLC | 11,736,283 5.900% | -728,691 (-5.85%) | View |
2022-02-15 2:48 pm Purchase | 13G | BCLS Acquisition Corp. BLSA | ACUTA CAPITAL PARTNERS LLC | 843,122 5.700% | 843,122 (New Position) | View |
2022-02-15 2:43 pm Sale | 13G | LARIMAR THERAPEUTICS INC LRMR | ACUTA CAPITAL PARTNERS LLC | 0 0.000% | -863,100 (Position Closed) | View |
2022-02-14 4:39 pm Sale | 13G | GYRE THERAPEUTICS INC. GYRE | ACUTA CAPITAL PARTNERS LLC | 0 0.000% | -1,357,500 (Position Closed) | View |
2021-09-07 5:25 pm Purchase | 13D | AADI BIOSCIENCE INC AADI | ACUTA CAPITAL PARTNERS LLC | 1,548,081 7.300% | 1,548,081 (New Position) | View |
2021-03-22 06:06 am Purchase | 13G | VISTAGEN THERAPEUTICS INC VTGN | ACUTA CAPITAL PARTNERS LLC | 12,464,974 8.400% | 4,964,974 (+66.20%) | View |
2021-02-16 06:14 am Purchase | 13G | GYRE THERAPEUTICS INC. GYRE | ACUTA CAPITAL PARTNERS LLC | 1,357,500 6.100% | 1,357,500 (New Position) | View |
2021-02-16 06:14 am Purchase | 13G | VISTAGEN THERAPEUTICS INC VTGN | ACUTA CAPITAL PARTNERS LLC | 7,500,000 5.400% | 7,500,000 (New Position) | View |
2021-02-16 06:11 am Purchase | 13G | LARIMAR THERAPEUTICS INC LRMR | ACUTA CAPITAL PARTNERS LLC | 863,100 5.600% | 863,100 (New Position) | View |
2021-02-16 06:11 am Purchase | 13G | Jiya Acquisition Corp. JYAC | ACUTA CAPITAL PARTNERS LLC | 562,500 5.200% | 562,500 (New Position) | View |
2020-02-14 10:43 am Sale | 13G | Kadmon Holdings Inc. KDMN | ACUTA CAPITAL PARTNERS LLC | 7,373,333 4.600% | -1,498,000 (-16.89%) | View |